DiA Imaging Analysis Ltd., which provides artificial intelligence-powered applications for ultrasound, announced on Tuesday a strategic partnership with Royal Philips to deliver automated solutions to clinicians at the point-of-care .
Follow Israel Hayom on Facebook and Twitter
DiA has developed FDA cleared and CE-marked AI-enabled 2D ultrasound cardiac and abdominal applications that are in use worldwide.
"This partnership with DiA reinforces Philips' commitment to integrating AI partners into the Radiology workflow ecosystem, from the modality, to interpretation, all the way through to results communication," said Kees Wesdorp, Chief Business Leader, Precision Diagnosis at Philips.
DiA Imaging Analysis co-founder and CEO Hila Goldman-Aslan said that "Philips Ultrasound devices are widely accepted as the industry's most advanced solution for point-of-care imaging. As such, it is the ideal platform for deploying AI-enabled solutions that will benefit patients by helping clinicians to make better-informed decisions."
DiA will spotlight its AI-enabled solutions across its imaging portfolio at the upcoming European Congress of Radiology 2021 virtual event, to be held March 3-7, 2021.
